Guerrilla RF, Inc. filed a Form 8-K on November 3, 2026, disclosing the appointment of Lauren Winslow as Executive Vice President of Sales and the departure of Chief Business Officer Kellie Chong, effective the same date.
SeaStar Medical Holding Corporation filed a Form 8-K on November 3, 2026, disclosing that the U.S. Food and Drug Administration determined that the QUELIMMUNE Pediatric SAVE Surveillance Registry has fulfilled its post-approval study requirements under the original Humanitarian Device Exemption approval.
Willis Lease Finance Corporation filed a Form 8-K with the SEC on November 3, 2026, reporting its results of operations for the three and nine months ended September 30, 2026, and its financial condition as of that date.
Ryanair Holdings plc filed a Form 6-K with the SEC on 3 November 2026, reporting October 2026 passenger traffic statistics showing guest numbers grew 1% year over year to over 19.4 million.
Prudential plc filed a Form 6-K on 3 November 2026 disclosing that Chief Executive Officer Anil Wadhwani acquired 1,836 ordinary shares on 2 November 2026 through dividend accruals on deferred share awards under the Annual Incentive Plan.
Director Eugene Williams of ProMIS Neurosciences Inc. filed a statement of changes in beneficial ownership on November 3, 2026, reporting a purchase of common shares on October 30, 2026.
Neil Cashman, Director and Chief Scientific Officer of ProMIS Neurosciences Inc., filed a Form 4 on November 3, 2026, reporting a purchase of 10,000 common shares on November 2, 2026.
Radware Ltd officer Gabi Malka filed a Form 144 notice of proposed sale of 16,461 ordinary shares, dated November 2, 2026, with the U.S. Securities and Exchange Commission.
Vital Farms, Inc. filed a Form 8-K/A on November 3, 2026, amending its May 7, 2026 original report to provide cost estimates for its butter product wind-down that were not reasonably estimable at the time of the original filing.
CVR Energy, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the Securities and Exchange Commission on November 3, 2026, covering financial and operational disclosures for the third quarter and first nine months of the year.